MetLife (NYSE:MET) Price Target Raised to $113.00

MetLife (NYSE:MET) had its price target increased by Wells Fargo & Company from $110.00 to $113.00 in a research report released on Thursday morning,Benzinga reports. They currently have an overweight rating on the financial services provider’s stock.

Several other equities analysts have also weighed in on MET. Weiss Ratings raised MetLife from a “buy (b)” rating to a “buy (b+)” rating in a research note on Monday, November 9th. Argus increased their target price on shares of MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. TD Cowen raised their price target on shares of MetLife from $110.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, October 21st. Morgan Stanley lifted their price target on shares of MetLife from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, August 24th. Finally, Wall Street Zen downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Fourteen investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $107.12.

MetLife Trading Up 0.8%

Shares of MET traded up $0.80 during trading hours on Thursday, hitting $102.67. The stock had a trading volume of 2,436,641 shares, compared to its average volume of 3,197,036. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.20 and a current ratio of 0.21. The firm has a market cap of $64.52 billion, a P/E ratio of 13.39, a P/E/G ratio of 0.96 and a beta of 0.79. The company’s fifty day simple moving average is $98.75 and its 200 day simple moving average is $86.90. MetLife has a 12-month low of $67.33 and a 12-month high of $106.72.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.77 by $0.01. The firm had revenue of $20.52 billion during the quarter, compared to the consensus estimate of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The firm’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.34 earnings per share. Equities research analysts forecast that MetLife will post 9.91 EPS for the current fiscal year.

MetLife announced that its Board of Directors has authorized a stock buyback program on Wednesday, August 5th that authorizes the company to repurchase $3 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Share repurchase programs are usually a sign that the company’s management believes its stock is undervalued.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be given a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a dividend yield of 2.3%. MetLife’s dividend payout ratio is presently 30.90%.

Insider Activity

In related news, CEO Michel Khalaf sold 187,425 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the sale, the chief executive officer directly owned 759,013 shares in the company, valued at approximately $78,155,568.61. This trade represents a 19.80% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.40% of the company’s stock.

Institutional Trading of MetLife

Large investors have recently bought and sold shares of the company. Nvwm LLC lifted its position in shares of MetLife by 655.3% during the third quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 249 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in MetLife during the 2nd quarter valued at $26,000. Burk Holdings LLC acquired a new stake in MetLife during the 2nd quarter valued at $27,000. Highland Investment Advisors LLC purchased a new stake in MetLife during the 2nd quarter worth $30,000. Finally, Meeder Asset Management Inc. increased its stake in MetLife by 156.5% during the 3rd quarter. Meeder Asset Management Inc. now owns 354 shares of the financial services provider’s stock worth $33,000 after buying an additional 216 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife News Roundup

These are some of the MET news items that stood out recently:

• Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
• Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
• Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article

About MetLife

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.